Brigatinib in Patients with ALK‐positive Anaplastic Large Cell Lymphoma Who Have Failed Brentuximab Vedotin
Hematological Oncology(2023)
Key words
ALK Inhibitors
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined